List of works by Gary Nabel

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

scientific article

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

scientific article published on April 2004

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

scientific article published on 26 September 2008

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

scientific article (publication date: 15 December 2007)

A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial

scientific article

A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys

scholarly article

A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions

scientific article

A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses

scientific article published on September 2006

A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression

scientific article

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

scientific article

A multiclade DNA/Ad vaccines for AIDS: the present and next generation.

scientific article published on 21 December 2006

A novel role for XIAP in copper homeostasis through regulation of MURR1

scientific article

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

scientific article (publication date: 2011)

A specific domain of the Chikungunya virus E2 protein regulates particle formation in human cells: implications for alphavirus vaccine design

scientific article

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

scientific article

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

scientific article

Accelerating next-generation vaccine development for global disease prevention

scientific article published on May 2013

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines

scientific article

Activation and lysis of human CD4 cells latently infected with HIV-1

scientific article

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

scientific article

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors

scientific article

Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline

scientific article

Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding

scientific article

Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity

scientific article

Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts

scientific article

Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens

scientific article published on 21 April 2012

Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection

scientific article published on 3 June 2015

Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning

scientific article published in September 2013

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

scientific article published on 21 August 2011

Cellular localization and function of Fas ligand (CD95L) in tumors

scientific article published on 01 March 2002

Characterization of human adenovirus 35 and derivation of complex vectors

scientific article published on October 19, 2010

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

scientific article

Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development

scientific article published on 26 October 2015

Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization

scientific article published on 6 February 2013

Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret

scientific article

Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus

scientific article published on 16 April 2008

Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model

scientific article published on 9 August 2005

Computational prediction of N-linked glycosylation incorporating structural properties and patterns

scientific article

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.

scientific article published on 31 May 2012

Correction: Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice.

scientific article

Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope

scientific article published on 18 April 2006

Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design

scientific article published on March 2010

Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen

scientific article

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

scientific article published on 03 October 2011

DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

scientific article

DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial

scientific article

Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination

scientific article (publication date: 2012)

Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity

scientific article published on 06 May 2009

Designing tomorrow's vaccines

scientific article published on February 2013

Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.

scientific article

Development of a Pan-H1 Influenza Vaccine

article

Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus

scientific article (publication date: 2013)

Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.

scientific article published on 7 February 2010

Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity

scientific article

Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization

scientific article published in January 2010

Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages

scientific article

Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytes.

scientific article

Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway

scientific article published on January 2005

Ebola virus pathogenesis: implications for vaccines and therapies

scientific article

Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus

scientific article

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

scientific article

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

scientific article

Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs

scientific article published on 7 November 2006

Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure

scientific article published on 01 August 2012

Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination

scientific article

Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens

scientific article

Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain

scientific article published on 04 March 2009

Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.

scientific article

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

scientific article

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

scientific article published on 13 August 2014

Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo

scientific article

Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys

scientific article

Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys

scientific article

Epstein-Barr virus: an important vaccine target for cancer prevention

scientific article

Erratum: An inducible transcription factor activates expression of human immunodeficiency virus in T cells

scientific article published in Nature

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

scientific article

Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination

scientific article published on 24 December 2008

Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate

scientific article

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

scientific article

Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

scientific article published on 05 February 2014

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

scientific article

Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates

scientific article

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization

scientific article published on 14 September 2008

Genetic immunization in the lung induces potent local and systemic immune responses

scientific article

Genetic, cellular and immune approaches to disease therapy: past and future

scientific article published on February 2004

Genital tract sequestration of SIV following acute infection

scientific article

Getting to the heart of influenza

scientific article published on June 2013

HIV integration and T cell death: additional commentary.

scientific article published on 09 December 2013

HIV vaccine design and the neutralizing antibody problem

scientific article published in March 2004

HIV vaccine strategies

scientific article

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

scientific article published on 30 July 2015

HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions

scientific article

HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration.

scientific article

HIV-1 diversity and vaccine development

scientific article published on 01 June 2002

HIV-1 vaccines and adaptive trial designs

scientific article published on April 2011

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

scientific article

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

scientific article

Hemorrhagic fever viruses as biological weapons: medical and public health management

scientific article

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

scientific article

Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors

scientific article

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

scientific article published on May 2011

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

scientific article (publication date: June 2006)

Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity

scientific article

Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

scientific article

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

scientific article published on December 1, 2003

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

scientific article published in May 2004

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

scientific article published on 18 December 2013

Immunology. Close to the edge: neutralizing the HIV-1 envelope

scientific article

Immunopathology of highly virulent pathogens: insights from Ebola virus

scientific article published on November 2007

Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol

scientific article published on January 2004

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

scientific article

Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine

scientific article published on 01 December 2010

Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies

scientific article

Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells

scientific article

Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

scientific article published on 04 May 2009

Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2

scientific article published on 8 November 2006

Mammalian production of an isotopically enriched outer domain of the HIV-1 gp120 glycoprotein for NMR spectroscopy.

scientific article

Mapping the future of HIV vaccines

scientific article published on 01 July 2007

Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells

scientific article

Medicine. The need for a global HIV vaccine enterprise

scientific article

Mining the B cell repertoire for broadly neutralizing monoclonal antibodies to HIV-1.

scientific article

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization

scientific article

Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization

scientific article

Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys

scientific article

Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies

scientific article

Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice

scientific article

Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins

scientific article published on January 2005

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

scientific article

New approaches to vaccination

scholarly article published 16 August 2013

No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys

scientific article

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

scientific article published on 28 November 2006

Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04

scientific article

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

scientific article

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

scientific article

Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses

scientific article

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

scientific article published on 8 November 2006

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

scientific article published on 8 November 2006

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

scientific article

Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)

scientific article

Philosophy of science. The coordinates of truth.

scientific article

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

scientific article

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

scholarly article

Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys

scientific article published in May 2006

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

scientific article published on June 2006

Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect

scientific article published on 30 April 2013

Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses

scientific article

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

scientific article (publication date: 2 February 2010)

Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase

scientific article published on February 2012

Progress in the rational design of an AIDS vaccine

scientific article

Protecting against future shock--inhalational anthrax

scientific article published on 01 July 2009

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

scientific article

Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.

scientific article

Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis

scientific article

Public health. Rethinking influenza

scientific article published in October 2009

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

scientific article (publication date: 13 August 2010)

Rational design of vaccines for AIDS and influenza

scientific article published on January 2012

Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.

scientific article published on September 2011

Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys

scientific article published on July 27, 2010

Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation

scientific article published on 31 October 2016

Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region

scientific article

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates

scientific article

Report of the 2014 Cent Gardes HIV Vaccine Conference - Part 1: Neutralizing Antibodies; Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October 2014.

scientific article published on 11 March 2015

Report of the 2014 Cent Gardes HIV Vaccine Conference-Part 2: Cell-mediated immunity, mucosal protection, and clinical trials: Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October, 2014.

scientific article published on 2 July 2015

Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012

scientific article published on 13 March 2013

Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012.

scientific article published on 18 April 2013

Report of the Cent Gardes HIV Vaccines Conference, Part 2: The cellular immune response. Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.

scientific article

Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.

scientific article published on 20 May 2016

Retrospective. Norman L. Letvin (1949-2012).

scientific article published in June 2012

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)

scientific article

Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial

scientific article

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

scientific article

Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects

scientific article published on April 2007

Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection

scientific article

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa

scientific article (publication date: 21 September 2010)

Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates

scientific article published on 5 October 2013

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

scientific article published on 14 August 2014

Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope

scientific article published on April 2004

Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells

scientific article

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

scientific article

Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines.

scientific article

Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses

scientific article published on 18 September 2008

Straight talk with...Gary Nabel. Interview by Elie Dolgin

scientific article published in March 2013

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

scientific article

Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120

scientific article

Structural and genetic basis for development of broadly neutralizing influenza antibodies

scientific article

Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16

scientific article

Structural definition of a conserved neutralization epitope on HIV-1 gp120

scientific article

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

scientific article

Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site

scientific article (publication date: May 2009)

Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection

scientific article published on 18 March 2015

Systemic and mucosal T-lymphocyte activation induced by recombinant adenovirus vaccines in rhesus monkeys

scientific article published on 05 August 2009

Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models

scientific article

T-cell vaccination reduces simian immunodeficiency virus levels in semen

scientific article published on 29 July 2009

The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity

scientific article published on 15 November 2006

The TRIM5 gene modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys

scientific article

The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein

scientific article published on August 2002

The changing face of HIV vaccine research

scientific article

The design and evaluation of HIV-1 vaccines

scientific article published on June 2012

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

scientific article

The need and challenges for development of an Epstein-Barr virus vaccine

scientific article published on April 2013

The rational design of an AIDS vaccine

scientific article published on February 2006

Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation.

scientific article published on November 2014

Vaccinate for the next H2N2 pandemic now.

scientific article

Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge

scientific article

Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates

scientific article

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

scientific article

Vaccine for AIDS and Ebola virus infection

scientific article

Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys

scientific article

Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

scientific article

Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

scientific article

Vaccines

scientific article published on 01 January 2011

Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection

scientific article

Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge

scientific article

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

scientific article